Skip to main content

Table 2 Coverage indicators South Africa a

From: Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study

  Coverage indicators in South Africa
  Point estimate Low estimate High estimate
Receiving ART, n 971,566 NA NA
Needing ART, n    
CD4 ≤200 1,700,000 1,500,000 2,000,000
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people) b 1,925,000 1,750,000 2,200,000
CD4 ≤350 2,600,000 2,500,000 2,800,000
CD4 ≤500c 4,100,000 3,950,000 4,340,000
All HIV-positive people 5,600,000 5,400,000 5,900,000
Coverage,%    
CD4 ≤200 56 65 48
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people)b 50 56 44
CD4 ≤350 37 39 35
CD4 ≤500c 24 25 22
All HIV-positive people 17 18 16
Needed to initiate ART, n    
CD4 ≤200 728,434 528,434 1,028,434
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people)b 952,444 778,444 1,228,444
CD4 ≤350 1,628,434 1,528,434 1,828,434
CD4 ≤500c 3,128,434 2,978,434 3,368,434
All HIV-positive people 4,628,434 4,428,434 4,928,434
  1. ART, antiretroviral therapy; CD4, CD4 cell count (expressed in cells/μl;); NA, not applicable.
  2. aSource: WHO Towards Universal Access report 2010 [23].
  3. bWe assumed 25% of those with CD4 cell counts of 200 to 350 μl to be eligible because of pregnancy or co-infection with tuberculosis.
  4. cNumber of people estimated to be between those eligible at 350 cells/μl or lower and those eligible under the strategy of ART for all HIV-infected people.